Fever in the returning traveler

Emergency Medicine Clinics of North America

Volumn 31, Issue 4, 2013, Pages 927-944

  Kotlyar, Simon ^a   Rice, Brian T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fever; Imported infectious disease; International travel; Tropical disease

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE DIARRHEA; BLOOD CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD HOSPITALIZATION; CLINICAL FEATURE; DELAYED DIAGNOSIS; DENGUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EARLY DIAGNOSIS; EOSINOPHILIA; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; INCUBATION TIME; INFECTION PREVENTION; LABORATORY DIAGNOSIS; MALARIA; MEDICAL HISTORY; MORBIDITY; ONSET AGE; PARAMEDICAL PERSONNEL; PARATYPHOID FEVER; PRIORITY JOURNAL; RASH; REVIEW; RICKETTSIOSIS; TRAVEL; TROPICAL DISEASE; TYPHOID FEVER;

FEVER; IMPORTED INFECTIOUS DISEASE; INTERNATIONAL TRAVEL; TROPICAL DISEASE;

BACTERIAL INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEVER; HEMORRHAGIC FEVERS, VIRAL; HUMANS; PARASITIC DISEASES; TRAVEL;

EID: 84886592486     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.emc.2013.07.001     Document Type: Review

References (63)

1. World Health Organization. International travel and health. 2012. Available at: Accessed March 6, 2013. http://www.who.int/ith/en.
2. Ryan E.T., Kain K.C. Health advice and immunizations for travelers. NEngl J Med 2000, 342(23):1716-1725.
3. Steffen R., deBernardis C., Banos A. Travel epidemiology-a global perspective. Int J Antimicrob Agents 2003, 21(2):89-95.
4. Steffen R., Rickenbach M., Wilhelm U., et al. Health problems after travel to developing countries. JInfect Dis 1987, 156(1):84-91.
5. Freedman D.O., Weld L.H., Kozarsky P.E., et al. Spectrum of disease and relation to place of exposure among ill returned travelers. NEngl J Med 2006, 354(2):119-130.
6. Bruni M., Steffen R. Impact of travel-related health impairments. JTravel Med 1997, 4(2):61-64.
7. Hill D.R. Health problems in a large cohort of Americans traveling to developing countries. JTravel Med 2000, 7(5):259-266.
8. Wilson M.E., Weld L.H., Boggild A., et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007, 44(12):1560-1568.
9. Leder K., Tong S., Weld L., et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006, 43(9):1185-1193.
10. Johnston V., Stockley J.M., Dockrell D., et al. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. JInfect 2009, 59(1):1-18.
11. Gautret P., Schlagenhauf P., Gaudart J., et al. Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis 2009, 15(11):1783-1790.
12. Bottieau E., Clerinx J., Schrooten W., et al. Etiology and outcome of fever after a stay in the tropics. Arch Intern Med 2006, 166(15):1642-1648.
13. O'Brien D., Tobin S., Brown G.V., et al. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001, 33(5):603-609.
14. O'Brien D.P., Leder K., Matchett E., et al. Illness in returned travelers and immigrants/refugees: the 6-year experience of two Australian infectious diseases units. JTravel Med 2006, 13(3):145-152.
15. Bottieau E., Clerinx J., Van den Enden E., et al. Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions. Medicine (Baltimore) 2007, 86(1):18-25.
16. Mali S., Tan K.R., Arguin P.M. Malaria surveillance-United States, 2009. MMWR Surveill Summ 2011, 60(3):1-15.
17. Spira A.M. Assessment of travellers who return home ill. Lancet 2003, 361(9367):1459-1469.
18. Memish Z.A. Meningococcal disease and travel. Clin Infect Dis 2002, 34(1):84-90.
19. Jelinek T., Bisoffi Z., Bonazzi L., et al. Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis 2002, 8(6):634-635.
20. Moore A.C., Ryan E.T., Waldron M.A. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2002. A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to Africa. NEngl J Med 2002, 346(26):2069-2076.
21. Rothenberg M.E. Eosinophilia. NEngl J Med 1998, 338(22):1592-1600.
22. Doherty J.F., Moody A.H., Wright S.G. Katayama fever: an acute manifestation of schistosomiasis. BMJ 1996, 313(7064):1071-1072.
23. Schulte C., Krebs B., Jelinek T., et al. Diagnostic significance of blood eosinophilia in returning travelers. Clin Infect Dis 2002, 34(3):407-411.
24. Antinori S., Galimberti L., Gianelli E., et al. Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. JTravel Med 2004, 11(3):135-142.
25. Parola P., Soula G., Gazin P., et al. Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999-2003. Travel Med Infect Dis 2006, 4(2):61-70.
26. Ansart S., Perez L., Vergely O., et al. Illnesses in travelers returning from the tropics: a prospective study of 622 patients. JTravel Med 2005, 12(6):312-318.
27. Casalino E., Le Bras J., Chaussin F., et al. Predictive factors of malaria in travelers to areas where malaria is endemic. Arch Intern Med 2002, 162(14):1625-1630.
28. West N.S., Riordan F.A. Fever in returned travellers: a prospective review of hospital admissions for a 2(1/2) year period. Arch Dis Child 2003, 88(5):432-434.
29. Herbinger K.H., Drerup L., Alberer M., et al. Spectrum of imported infectious diseases among children and adolescents returning from the tropics and subtropics. JTravel Med 2012, 19(3):150-157.
30. Naudin J., Blonde R., Alberti C., et al. Aetiology and epidemiology of fever in children presenting to the emergency department of a French paediatric tertiary care centre after international travel. Arch Dis Child 2012, 97(2):107-111.
31. Hagmann S., Neugebauer R., Schwartz E., et al. Illness in children after international travel: analysis from the GeoSentinel Surveillance Network. Pediatrics 2010, 125(5):e1072-e1080.
32. Mali S., Kachur S.P., Arguin P.M. Malaria surveillance-United States, 2010. MMWR Surveill Summ 2012, 61(2):1-17.
33. Smith A.D., Bradley D.J., Smith V., et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006. BMJ 2008, 337:a120.
34. Severe falciparum malaria. World Health Organization, communicable diseases cluster. Trans R Soc Trop Med Hyg 2000, 94(Suppl 1):S1-S90.
35. Dorsey G., Gandhi M., Oyugi J.H., et al. Difficulties in the prevention, diagnosis, and treatment of imported malaria. Arch Intern Med 2000, 160(16):2505-2510.
36. Nic Fhogartaigh C., Hughes H., Armstrong M., et al. Falciparum malaria as a cause of fever in adult travellers returning to the United Kingdom: observational study of risk by geographical area. QJM 2008, 101(8):649-656.
37. Stauffer W.M., Cartwright C.P., Olson D.A., et al. Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. Clin Infect Dis 2009, 49(6):908-913.
38. Dondorp A., Nosten F., Stepniewska K., et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005, 366(9487):717-725.
39. Dondorp A.M., Fanello C.I., Hendriksen I.C., et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010, 376(9753):1647-1657.
40. Rosenthal P.J. Artesunate for the treatment of severe falciparum malaria. NEngl J Med 2008, 358(17):1829-1836.
41. Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service. MMWR Recomm Rep 1991, 40(RR-4):21-23.
42. Wilder-Smith A., Schwartz E. Dengue in travelers. NEngl J Med 2005, 353(9):924-932.
43. Gubler D.J., Clark G.G. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995, 1(2):55-57.
44. Mohammed H.P., Ramos M.M., Rivera A., et al. Travel-associated dengue infections in the United States, 1996 to 2005. JTravel Med 2010, 17(1):8-14.
45. Gibbons R.V., Vaughn D.W. Dengue: an escalating problem. BMJ 2002, 324(7353):1563-1566.
46. Wilder-Smith A., Renhorn K.E., Tissera H., et al. DengueTools: innovative tools and strategies for the surveillance and control of dengue. Glob Health Action 2012, 5:17274.
47. Centers for Disease Control and Prevention (CDC) Travel-associated Dengue surveillance-United States, 2006-2008. MMWR Morb Mortal Wkly Rep 2010, 59(23):715-719.
48. Halstead S.B. Dengue. Lancet 2007, 370(9599):1644-1652.
49. Guzman M.G., Kouri G. Dengue: an update. Lancet Infect Dis 2002, 2(1):33-42.
50. Wichmann O., Gascon J., Schunk M., et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. JInfect Dis 2007, 195(8):1089-1096.
51. Dung N.M., Day N.P., Tam D.T., et al. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 1999, 29(4):787-794.
52. Crump J.A., Luby S.P., Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 2004, 82(5):346-353.
53. Bhan M.K., Bahl R., Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005, 366(9487):749-762.
54. Hosoglu S., Aldemir M., Akalin S., et al. Risk factors for enteric perforation in patients with typhoid Fever. Am J Epidemiol 2004, 160(1):46-50.
55. Vallenas C., Hernandez H., Kay B., et al. Efficacy of bone marrow, blood, stool and duodenal contents cultures for bacteriologic confirmation of typhoid fever in children. Pediatr Infect Dis 1985, 4(5):496-498.
56. World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever 2003, World Health Organization, Geneva (Switzerland).
57. Bhutta Z.A. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006, 333(7558):78-82.
58. Threlfall E.J., de Pinna E., Day M., et al. Alternatives to ciprofloxacin use for enteric fever, United kingdom. Emerg Infect Dis 2008, 14(5):860-861.
59. Jensenius M., Davis X., von Sonnenburg F., et al. Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerg Infect Dis 2009, 15(11):1791-1798.
60. Jelinek T., Loscher T. Clinical features and epidemiology of tick typhus in travelers. JTravel Med 2001, 8(2):57-59.
61. Jensenius M., Fournier P.E., Vene S., et al. African tick bite fever in travelers to rural sub-Equatorial Africa. Clin Infect Dis 2003, 36(11):1411-1417.
62. Raoult D., Zuchelli P., Weiller P.J., et al. Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984. JInfect 1986, 12(2):111-116.
63. Dumler J.S., Taylor J.P., Walker D.H. Clinical and laboratory features of murine typhus in south Texas, 1980 through 1987. JAMA 1991, 266(10):1365-1370.